How many stocks are there of Saniona?
The current number of stocks of Saniona is 74.54 M undefined.
Saniona Stocks 2024
Saniona Stocks
74.54 M
Ticker
SANION.ST
ISIN
SE0005794617
WKN
A110VV
In 2024, Saniona had 74.54 M outstanding stocks, a 0% change from the 74.54 M stocks in the previous year.
The Saniona Stocks history
| YEAR | NUMBER OF STOCKS (undefined SEK) |
|---|---|
| 2024e | 74.54 |
| 2023 | 74.54 |
| 2022 | 73.73 |
| 2021 | 73.73 |
| 2020 | 48.45 |
| 2019 | 25.72 |
| 2018 | 22.92 |
| 2017 | 22.02 |
| 2016 | 21.43 |
| 2015 | 18.28 |
| 2014 | 13.6 |
| 2013 | 10.28 |
Saniona shares outstanding SE0005794617 · A110VV
The number of shares was Saniona in 2023 — This indicates how many shares 74.537 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Saniona earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Saniona's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Saniona’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Saniona's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2013 | 10.28 M Aktien |
| 2014 | 13.6 M Aktien |
| 2015 | 18.28 M Aktien |
| 2016 | 21.43 M Aktien |
| 2017 | 22.02 M Aktien |
| 2018 | 22.92 M Aktien |
| 2019 | 25.72 M Aktien |
| 2020 | 48.45 M Aktien |
| 2021 | 73.73 M Aktien |
| 2022 | 73.73 M Aktien |
| 2023 | 74.54 M Aktien |
| 2024e | 74.54 M Aktien |
Saniona Aktienanalyse
What does Saniona do?
Saniona AB is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutics for rare diseases. The company was previously known as Saniona AB (until 2014) and NeuroNova AB (until 2012). It was founded in Copenhagen, Denmark, in 2006 and quickly expanded to other countries. In 2013, the company opened an office in Boston, USA, to expand its activities in North America. Saniona AB is listed on the NASDAQ Stockholm and currently has over 60 employees worldwide. The company's business model revolves around discovering and developing drugs for rare diseases that have little to no existing therapies. They use a proprietary technology platform called Ion Channels and G Protein-Coupled Receptors (GPCRs) to identify novel compounds that could meet these urgent medical needs. Saniona AB aims to develop successful medications and sell them either through partnerships or their own marketing activities. The company operates in various areas, including rare diseases, the nervous system (developing drugs for movement disorders and psychiatric disorders), and diabetes and obesity. Saniona AB has several drug candidates in its pipeline targeting different therapeutic applications, with some in various stages of clinical development. One of its key products is Tesomet, a candidate for the treatment of Prader-Willi syndrome and hypothalamic-pituitary hormone disorders, which is currently in Phase 3 of clinical development. Another important candidate is AN788, being investigated in Phase 2 clinical studies for the treatment of idiopathic pulmonary fibrosis. In conclusion, Saniona AB is an emerging biopharmaceutical company developing innovative drugs for rare diseases. With a specialization in researching rare diseases with significant medical needs and unmet treatment options, the company utilizes a proprietary technology platform to identify new compounds that aim to fulfill these medical needs. With multiple drug candidates in development and a strong partnership strategy, Saniona is well-positioned to maximize the potential of its innovative therapies and benefit patients in need. Saniona ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Saniona's Shares Outstanding
Saniona's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Saniona’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Saniona’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Saniona’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Saniona stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Saniona are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Saniona evolved in recent years?
The number of shares of Saniona has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Saniona as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Saniona?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Saniona pay?
Over the past 12 months, Saniona paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Saniona is expected to pay a dividend of 0 SEK.
What is the dividend yield of Saniona?
The current dividend yield of Saniona is .
When does Saniona pay dividends?
Saniona pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Saniona?
Saniona paid dividends every year for the past 0 years.
What is the dividend of Saniona?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Saniona located?
Saniona is assigned to the 'Health' sector.
Wann musste ich die Aktien von Saniona kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Saniona from 11/3/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.
When did Saniona pay the last dividend?
The last dividend was paid out on 11/3/2024.
What was the dividend of Saniona in the year 2023?
In the year 2023, Saniona distributed 0 SEK as dividends.
In which currency does Saniona pay out the dividend?
The dividends of Saniona are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Saniona
Our stock analysis for Saniona Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Saniona Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
